Bo Angelin

Om mig
Publikationer
Populärvetenskap och samverkan

Om mig

Professor i klinisk metabolisk forskning.

Leder Integrated Cardio Metabolic Centre (ICMC), ett forskningscenter som drivs gemensamt av Karolinska Institutet och AstraZeneca.

Artiklar

Article: ATHEROSCLEROSIS. 2024;389:117439

Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia.

Wodaje T; Mahdi A; Venkateshvaran A; Häbel H; Zenlander R; Gaylard B; Angelin B; Pernow J; Brinck J
Article: HEPATOLOGY. 2023;78(3):709-726

A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans.

Caballero-Camino FJ; Rodrigues PM; Wångsell F; Agirre-Lizaso A; Olaizola P; Izquierdo-Sanchez L; Perugorria MJ; Bujanda L; Angelin B; Straniero S; Wallebäck A; Starke I; Gillberg P-G; Strängberg E; Bonn B; Mattsson JP; Madsen MR; Hansen HH; Lindström E; Åkerblad P; Banales JM
Article: COMMUNICATIONS BIOLOGY. 2022;5(1):1057

Molecular programming modulates hepatic lipid metabolism and adult metabolic risk in the offspring of obese mothers in a sex-specific manner.

Savva C; Helguero LA; González-Granillo M; Melo T; Couto D; Angelin B; Domingues MR; Li X; Kutter C; Korach-André M
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(2):404-415

Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.

Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
Article: COMMUNICATIONS BIOLOGY. 2021;4(1):14

Obese mother offspring have hepatic lipidic modulation that contributes to sex-dependent metabolic adaptation later in life.

Savva C; Helguero LA; González-Granillo M; Couto D; Melo T; Li X; Angelin B; Domingues MR; Kutter C; Korach-André M
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(5):534-545

Regulation of bile acid metabolism in biliary atresia: reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome.

Johansson H; Svensson JF; Almström M; Van Hul N; Rudling M; Angelin B; Nowak G; Fischler B; Ellis E
Article: JOURNAL OF LIPID RESEARCH. 2020;61(4):480-491

Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism.

Straniero S; Laskar A; Savva C; Härdfeldt J; Angelin B; Rudling M
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2020;502:110672

Selective estrogen receptor (ER)β activation provokes a redistribution of fat mass and modifies hepatic triglyceride composition in obese male mice.

González-Granillo M; Savva C; Li X; Ghosh Laskar M; Angelin B; Gustafsson J-Å; Korach-André M
Article: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2020;10(1):149-170

A Physiology-Based Model of Bile Acid Distribution and Metabolism Under Healthy and Pathologic Conditions in Human Beings.

Voronova V; Sokolov V; Al-Khaifi A; Straniero S; Kumar C; Peskov K; Helmlinger G; Rudling M; Angelin B
Article: JOURNAL OF INTERNAL MEDICINE. 2018;284(5):546-559

Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism.

Al-Khaifi A; Straniero S; Voronova V; Chernikova D; Sokolov V; Kumar C; Angelin B; Rudling M
Article: GASTROENTEROLOGY. 2018;155(4):1012-1016

An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers.

Al-Khaifi A; Rudling M; Angelin B
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2017;313(2):E167-E174

Cholestyramine treatment of healthy humans rapidly induces transient hypertriglyceridemia when treatment is initiated.

Sjöberg BG; Straniero S; Angelin B; Rudling M
Article: JOURNAL OF INTERNAL MEDICINE. 2017;281(6):575-585

Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III.

Ghosh Laskar M; Eriksson M; Rudling M; Angelin B
Article: CLINICAL OBESITY. 2017;7(1):1-10

Mental distress in treatment seeking young adults (18-25 years) with severe obesity compared with population controls of different body mass index levels: cohort study.

Dreber H; Reynisdottir S; Angelin B; Tynelius P; Rasmussen F; Hemmingsson E
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2017;47(1):38-43

High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.

Frias MA; Thomas A; Brulhart-Meynet M-C; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2016;36(5):787-791

Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report.

Apro J; Tietge UJF; Dikkers A; Parini P; Angelin B; Rudling M
Article: JOURNAL OF INTERNAL MEDICINE. 2016;279(5):477-484

Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels.

Kovamees O; Shemyakin A; Eriksson M; Angelin B; Pernow J
Article: PLOS ONE. 2016;11(2):e0148802

Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans.

Lehtihet M; Bonde Y; Beckman L; Berinder K; Hoybye C; Rudling M; Sloan JH; Konrad RJ; Angelin B
Article: JOURNAL OF LIPID RESEARCH. 2015;56(8):1633-1639

Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients.

Apro J; Parini P; Broijersén A; Angelin B; Rudling M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2015;461(4):592-597

Influence of dietary sugar on cholesterol and bile acid metabolism in the rat: Marked reduction of hepatic Abcg5/8 expression following sucrose ingestion.

Apro J; Beckman L; Angelin B; Rudling M
Article: JOURNAL OF INTERNAL MEDICINE. 2015;277(3):331-342

Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome.

Angelin B; Kristensen JD; Eriksson M; Carlsson B; Klein I; Olsson AG; Chester Ridgway E; Ladenson PW
Article: JOURNAL OF LIPID RESEARCH. 2015;56(2):463-469

Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.

Ghosh M; Gälman C; Rudling M; Angelin B
Article: PLOS ONE. 2015;10(12):e0145273

Who is the Treatment-Seeking Young Adult with Severe Obesity: A Comprehensive Characterization with Emphasis on Mental Health.

Dreber H; Reynisdottir S; Angelin B; Hemmingsson E
Article: JOURNAL OF LIPID RESEARCH. 2014;55(11):2408-2415

Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans.

Bonde Y; Breuer O; Lütjohann D; Sjöberg S; Angelin B; Rudling M
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(3):227-232

Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans.

Lundberg J; Höybye C; Krusenstjerna-Hafstrøm T; Bina HA; Kharitonenkov A; Angelin B; Rudling M
Article: CELL METABOLISM. 2013;17(2):225-235

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.

Sayin SI; Wahlström A; Felin J; Jäntti S; Marschall H-U; Bamberg K; Angelin B; Hyötyläinen T; Orešič M; Bäckhed F
Article: HEPATOLOGY. 2012;56(5):1828-1837

Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex.

Bonde Y; Plösch T; Kuipers F; Angelin B; Rudling M
Article: CLINICAL CHEMISTRY. 2012;58(8):1225-1232

Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration.

Troutt JS; Rudling M; Persson L; Ståhle L; Angelin B; Butterfield AM; Schade AE; Cao G; Konrad RJ
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2012;32(3):810-814

Endogenous estrogens lower plasma PCSK9 and LDL cholesterol but not Lp(a) or bile acid synthesis in women.

Persson L; Henriksson P; Westerlund E; Hovatta O; Angelin B; Rudling M
Article: PLOS ONE. 2012;7(5):e37787

Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice.

Lundåsen T; Andersson E-M; Snaith M; Lindmark H; Lundberg J; Östlund-Lindqvist A-M; Angelin B; Rudling M
Article: JOURNAL OF INTERNAL MEDICINE. 2011;270(6):580-588

Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19.

Gälman C; Angelin B; Rudling M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2010;30(12):2666-2672

Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans.

Persson L; Cao G; Ståhle L; Sjöberg BG; Troutt JS; Konrad RJ; Gälman C; Wallén H; Eriksson M; Hafström I; Lind S; Dahlin M; Amark P; Angelin B; Rudling M
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2010;362(10):906-916

Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.

Ladenson PW; Kristensen JD; Ridgway EC; Olsson AG; Carlsson B; Klein I; Baxter JD; Angelin B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2009;29(8):1235-1241

Control of ACAT2 liver expression by HNF4{alpha}: lesson from MODY1 patients.

Pramfalk C; Karlsson E; Groop L; Rudel LL; Angelin B; Eriksson M; Parini P
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2009;38(3):184-189

Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease.

Hua X; Su J; Svenungsson E; Hurt-Camejo E; Jensen-Urstad K; Angelin B; Båvenholm P; Frostegård J
Article: ENDOCRINOLOGY. 2009;150(3):1140-1146

Importance of proprotein convertase subtilisin/kexin type 9 in the hormonal and dietary regulation of rat liver low-density lipoprotein receptors.

Persson L; Gälman C; Angelin B; Rudling M
Article: CELL METABOLISM. 2008;8(2):169-174

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

Gälman C; Lundåsen T; Kharitonenkov A; Bina HA; Eriksson M; Hafström I; Dahlin M; Amark P; Angelin B; Rudling M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2008;28(6):1200-1206

Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.

Parini P; Gustafsson U; Davis MA; Larsson L; Einarsson C; Wilson M; Rudling M; Tomoda H; Omura S; Sahlin S; Angelin B; Rudel LL; Eriksson M
Article: GASTROENTEROLOGY. 2008;134(4):1127-1136

Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone.

Gälman C; Bonde Y; Matasconi M; Angelin B; Rudling M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008;105(2):663-667

The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.

Berkenstam A; Kristensen J; Mellström K; Carlsson B; Malm J; Rehnmark S; Garg N; Andersson CM; Rudling M; Sjöberg F; Angelin B; Baxter JD
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007;364(2):402-409

Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells.

Pramfalk C; Angelin B; Eriksson M; Parini P
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2007;293(3):E737-E742

Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol.

Gälman C; Matasconi M; Persson L; Parini P; Angelin B; Rudling M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007;360(2):437-440

PPARalpha is a key regulator of hepatic FGF21.

Lundåsen T; Hunt MC; Nilsson L-M; Sanyal S; Angelin B; Alexson SEH; Rudling M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007;357(3):707-711

Bile acids and lipoprotein metabolism: effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression.

Nilsson L-M; Abrahamsson A; Sahlin S; Gustafsson U; Angelin B; Parini P; Einarsson C
Article: JOURNAL OF INTERNAL MEDICINE. 2006;260(6):530-536

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

Lundåsen T; Gälman C; Angelin B; Rudling M
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2006;36(2):98-104

Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system.

Parini P; Johansson L; Bröijersén A; Angelin B; Rudling M
Article: GASTROENTEROLOGY. 2005;129(5):1445-1453

Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis.

Gälman C; Angelin B; Rudling M
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2005;1736(3):221-227

Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: effects of hypophysectomy and growth hormone treatment.

Matasconi M; Parini P; Angelin B; Rudling M
Article: ATHEROSCLEROSIS. 2005;182(1):37-45

Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration.

Abrahamsson A; Krapivner S; Gustafsson U; Muhrbeck O; Eggertsen G; Johansson I; Persson I; Angelin B; Ingelman-Sundberg M; Björkhem I; Einarsson C; van't Hooft FM
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005;102(29):10297-10302

Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.

Johansson L; Rudling M; Scanlan TS; Lundåsen T; Webb P; Baxter J; Angelin B; Parini P
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2005;25(5):1057-1064

Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.

Brousseau ME; Diffenderfer MR; Millar JS; Nartsupha C; Asztalos BF; Welty FK; Wolfe ML; Rudling M; Björkhem I; Angelin B; Mancuso JP; Digenio AG; Rader DJ; Schaefer EJ
Article: JOURNAL OF INTERNAL MEDICINE. 2004;256(5):406-412

Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment.

Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B
Article: ENDOCRINOLOGY. 2004;145(11):4897-4911

Prenatal exposure to interleukin-6 results in hypertension and increased hypothalamic-pituitary-adrenal axis activity in adult rats.

Samuelsson A-M; Ohrn I; Dahlgren J; Eriksson E; Angelin B; Folkow B; Holmäng A
Article: CIRCULATION. 2004;110(14):2017-2023

ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver.

Parini P; Davis M; Lada AT; Erickson SK; Wright TL; Gustafsson U; Sahlin S; Einarsson C; Eriksson M; Angelin B; Tomoda H; Omura S; Willingham MC; Rudel LL
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2004;287(1):E114-E119

Pituitary control of lipoprotein and bile acid metabolism in male rats: growth hormone effects are not mediated by prolactin.

Matasconi M; Angelin B; Rudling M
Article: CIRCULATION RESEARCH. 2004;94(12):1579-1588

Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice.

Bråkenhielm E; Cao R; Gao B; Angelin B; Cannon B; Parini P; Cao Y
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2004;24(2):349-356

Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans.

Lind S; Rudling M; Ericsson S; Olivecrona H; Eriksson M; Borgström B; Eggertsen G; Berglund L; Angelin B
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2003;278(44):43224-43228

Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice.

Lundåsen T; Liao W; Angelin B; Rudling M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003;105(2):266-273

Reduction in serum levels of antimitochondrial (M2) antibodies following immunoglobulin therapy in severe combined immunodeficient (SCID) mice reconstituted with lymphocytes from patients with primary biliary cirrhosis (PBC).

Abedi MR; Hammarström L; Broomé U; Angelin B; Smith CI; Christensson B
Article: NATURE GENETICS. 2003;34(1):29-31

Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders.

Jones B; Jones EL; Bonney SA; Patel HN; Mensenkamp AR; Eichenbaum-Voline S; Rudling M; Myrdal U; Annesi G; Naik S; Meadows N; Quattrone A; Islam SA; Naoumova RP; Angelin B; Infante R; Levy E; Roy CC; Freemont PS; Scott J; Shoulders CC
Article: JOURNAL OF LIPID RESEARCH. 2003;44(4):859-866

Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood.

Gälman C; Arvidsson I; Angelin B; Rudling M
Article: FASEB JOURNAL. 2003;17(2):265-267

Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency.

Gälman C; Ostlund-Lindqvist A-M; Björquist A; Schreyer S; Svensson L; Angelin B; Rudling M
Article: ATHEROSCLEROSIS SUPPLEMENTS. 2002;3(4):23-30

Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL.

Angelin B; Parini P; Eriksson M
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2002;87(9):4307-4313

Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver.

Rudling M; Angelin B; Ståhle L; Reihnér E; Sahlin S; Olivecrona H; Björkhem I; Einarsson C
Article: CIRCULATION. 2002;106(9):1147-1153

Accumulation of foam cells in liver X receptor-deficient mice.

Schuster GU; Parini P; Wang L; Alberti S; Steffensen KR; Hansson GK; Angelin B; Gustafsson J-A
Article: MOLECULAR ENDOCRINOLOGY. 2002;16(8):1767-1777

Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice.

Gullberg H; Rudling M; Saltó C; Forrest D; Angelin B; Vennström B
Article: ATHEROSCLEROSIS. 2002;163(2):399-407

Genetic characterization of Swedish patients with familial hypercholesterolemia: a heterogeneous pattern of mutations in the LDL receptor gene.

Lind S; Rystedt E; Eriksson M; Wiklund O; Angelin B; Eggertsen G
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2002;277(30):26804-26807

Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1.

Björkhem I; Araya Z; Rudling M; Angelin B; Einarsson C; Wikvall K
Article: ENDOCRINOLOGY. 2002;143(5):1809-1816

Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol.

Gälman C; Angelin B; Rudling M
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2002;1581(1-2):36-48

Dexamethasone stimulates very low density lipoprotein (VLDL) receptor gene expression in differentiating 3T3-L1 cells.

Ensler K; Mohammadieh M; Bröijersén A; Angelin B; Gåfvels M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2001;21(12):2039-2045

Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia.

Love MW; Craddock AL; Angelin B; Brunzell JD; Duane WC; Dawson PA
Article: FASEB JOURNAL. 2001;15(8):1350-1356

Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice.

Rudling M; Angelin B
Article: JOURNAL OF CLINICAL INVESTIGATION. 2001;107(5):565-573

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice.

Alberti S; Schuster G; Parini P; Feltkamp D; Diczfalusy U; Rudling M; Angelin B; Björkhem I; Pettersson S; Gustafsson JA
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2000;278(3):640-645

Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice.

Ohlsson C; Hellberg N; Parini P; Vidal O; Bohlooly-Y M; Rudling M; Lindberg MK; Warner M; Angelin B; Gustafsson JA
Article: MOLECULAR ENDOCRINOLOGY. 2000;14(11):1739-1749

Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol.

Gullberg H; Rudling M; Forrest D; Angelin B; Vennström B
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2000;30(10):866-870

LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion.

Stenvinkel P; Alvestrand A; Angelin B; Eriksson M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2000;20(7):1817-1823

Biphasic effects of the natural estrogen 17beta-estradiol on hepatic cholesterol metabolism in intact female rats.

Parini P; Angelin B; Stavréus-Evers A; Freyschuss B; Eriksson H; Rudling M
Article: CONTROL AND CYBERNETICS. 2000;29(1):405-425

Kinetic analysis of LDL apoB transport and metabolism in non-steady states

Werynski A; Nahorski Z; Angelin B; Berglund L; Eriksson M
Article: UGESKRIFT FOR LAEGER. 1999;161(51):7071-7076

[Gunter Blobel, the 1999 Nobel Prize winner in physiology or medicine. Proteins in the cell are directed by built-in "zip codes"].

Pettersson RF; Angelin B; Daneholt B
Article: HEPATOLOGY. 1999;30(5):1252-1256

Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the toll-like receptor 4.

Liao W; Rudling M; Angelin B
Article: LAKARTIDNINGEN. 1999;96(42):4507-4512

[Günter Blobel the 1999 Nobel Prize-winner in physiology and medicine. Proteins are directed in the cell through by built-in "zip-codes"].

Pettersson RF; Angelin B; Daneholt B
Article: JOURNAL OF INTERNAL MEDICINE. 1999;246(4):399-407

Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity.

Hillebrant C; Nyberg B; Angelin B; Axelson M; Björkhem I; Rudling M; Einarsson C
Article: CIRCULATION. 1999;100(6):594-598

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans.

Eriksson M; Carlson LA; Miettinen TA; Angelin B
Article: PHARMACOLOGY. 1999;59(1):51-56

Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man.

Berglund L; Galbraith RA; Emtestam L; Drummond GS; Angelin B; Kappas A
Article: EUROPEAN JOURNAL OF PHARMACOLOGY. 1999;374(3):471-476

Endogenous histamine reduces plasma insulin-like growth factor I via H1 receptor-mediated pathway in the rat.

Liao W; Rudling M; Möller C; Angelin B
Article: JOURNAL OF LIPID RESEARCH. 1999;40(5):913-919

VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor.

Nilsson L; Gåfvels M; Musakka L; Ensler K; Strickland DK; Angelin B; Hamsten A; Eriksson P
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1999;29(4):291-300

Evidence of circadian rhythm in low-density lipoprotein apoB catabolism and its impact on the estimation of kinetic parameters.

Weryński A; Nahorski Z; Berglund L; Ericsson S; Angelin B; Eriksson M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1999;19(4):832-839

Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats.

Parini P; Angelin B; Rudling M
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1999;84(2):553-560

Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.

Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
Article: AMERICAN JOURNAL OF PATHOLOGY. 1998;153(6):1923-1935

Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation.

Rudling M; Gåfvels M; Parini P; Gahrton G; Angelin B
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1998;1394(2-3):153-157

The level of 7-dehydrocholesterol in plasma reflects the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the human liver.

Axelson M; Angelin B; Hillebrant CG; Reihnér E; Einarsson C
Article: JOURNAL OF LIPID RESEARCH. 1998;39(11):2172-2181

Bovine aortic endothelial cells express a variant of the very low density lipoprotein receptor that lacks the O-linked sugar domain.

Magrané J; Reina M; Pagan R; Luna A; Casaroli-Marano RP; Angelin B; Gåfvels M; Vilaró S
Article: JOURNAL OF INTERNAL MEDICINE. 1998;244(1):19-25

Low frequency of the common Norwegian and Finnish LDL-receptor mutations in Swedish patients with familial hypercholesterolaemia.

Lind S; Eriksson M; Rystedt E; Wiklund O; Angelin B; Eggertsen G
Article: MOLECULAR HUMAN REPRODUCTION. 1998;4(6):585-593

Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor.

Casslén B; Gustavsson B; Angelin B; Gåfvels M
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1998;28(3):235-242

Gemfibrozil-induced decrease in serum ubiquinone and alpha- and gamma-tocopherol levels in men with combined hyperlipidaemia.

Aberg F; Appelkvist EL; Bröijersén A; Eriksson M; Angelin B; Hjemdahl P; Dallner G
Article: THROMBOSIS AND HAEMOSTASIS. 1998;79(2):268-275

Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia.

Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Article: ATHEROSCLEROSIS. 1997;135(1):109-118

Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS).

Held C; Hjemdahl P; Rehnqvist N; Björkander I; Forslund L; Brodin U; Berglund L; Angelin B
Article: JOURNAL OF INTERNAL MEDICINE. 1997;242(4):329-337

The influence of age on low density lipoprotein metabolism: effects of cholestyramine treatment in young and old healthy male subjects.

Ericsson S; Berglund L; Frostegård J; Einarsson K; Angelin B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1997;17(10):2287-2292

Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.

Reynisdottir S; Angelin B; Langin D; Lithell H; Eriksson M; Holm C; Arner P
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1997;17(9):1800-1805

Importance of estrogen receptors in hepatic LDL receptor regulation.

Parini P; Angelin B; Rudling M
Article: ENDOCRINOLOGY. 1997;138(8):3276-3282

Lipoprotein metabolism in the fat Zucker rat: reduced basal expression but normal regulation of hepatic low density lipoprotein receptors.

Liao W; Angelin B; Rudling M
Article: HEPATOLOGY. 1997;25(6):1447-1450

Hepatic cholesterol metabolism in human obesity.

Ståhlberg D; Rudling M; Angelin B; Björkhem I; Forsell P; Nilsell K; Einarsson K
Article: JOURNAL OF CLINICAL INVESTIGATION. 1997;99(9):2239-2245

Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat.

Rudling M; Parini P; Angelin B
Article: ENDOCRINOLOGY. 1997;138(5):1863-1870

Novel effects of histamine on lipoprotein metabolism: suppression of hepatic low density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat.

Liao W; Rudling M; Angelin B
Article: LIPIDS. 1997;32(3):255-262

Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies.

Vitols S; Angelin B; Juliusson G
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1997;17(2):273-278

No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia.

Bröijersén A; Eriksson M; Leijd B; Angelin B; Hjemdahl P
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1997;27(2):169-177

Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.

Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
Article: TRANSPLANTATION. 1997;63(1):74-80

Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus.

Ericzon BG; Eusufzai S; Söderdahl G; Duraj F; Einarsson K; Angelin B
Article: JOURNAL OF INTERNAL MEDICINE. 1997;241(1):59-69

Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controls.

Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Forslund L; Björkander I; Angelin B; Wiman B
Article: ENDOCRINOLOGY. 1997;138(1):289-295

Contrasting effects of growth hormone and insulin-like growth factor I on the biological activities of endotoxin in the rat.

Liao W; Rudling M; Angelin B
Article: DRUG METABOLISM AND DISPOSITION. 1996;24(9):962-968

Metabolism and excretion of ropivacaine in humans.

Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
Article: BIOLOGICAL PSYCHIATRY. 1996;40(4):302-304

Cholesterol lowering and cerebrospinal fluid neurotransmitters: increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteers.

Eriksson M; Eklundh T; Sjöberg S; Angelin B; Nordin C
Article: THROMBOSIS AND HAEMOSTASIS. 1996;76(2):171-176

Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.

Bröijersén A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
Article: JOURNAL OF LIPID RESEARCH. 1996;37(8):1733-1742

VLDL receptor mediates the uptake of human chylomicron remnants in vitro.

Niemeier A; Gàfvels M; Heeren J; Meyer N; Angelin B; Beisiegel U
Article: JOURNAL OF HEPATOLOGY. 1996;25(1):43-48

Bile acid kinetics and biliary lipid composition in cystic fibrosis.

Strandvik B; Einarsson K; Lindblad A; Angelin B
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(7):2633-2637

Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males.

Berglund L; Carlström K; Stege R; Gottlieb C; Eriksson M; Angelin B; Henriksson P
Article: AMERICAN JOURNAL OF PATHOLOGY. 1996;148(6):1985-1997

Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry.

Multhaupt HA; Gåfvels ME; Kariko K; Jin H; Arenas-Elliot C; Goldman BI; Strauss JF; Angelin B; Warhol MJ; McCrae KR
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1996;16(4):511-516

Gemfibrozil treatment of combined hyperlipoproteinemia. No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels.

Bröijersen A; Eriksson M; Wiman B; Angelin B; Hjemdahl P
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1996;26(3):254-258

Growth hormone potentiates the in vivo biological activities of endotoxin in the rat.

Liao W; Rudling M; Angelin B
Article: JOURNAL OF INTERNAL MEDICINE. 1996;239(2):177-180

Increased prevalence of atherosclerotic wall changes in patients with hyperlipidaemia after renal transplantation.

Jogestrand T; Fehrman-Ekholm I; Angelin B; Berglund L; Gäbel H
Article: BIOCHEMICAL JOURNAL. 1996;313 ( Pt 3)(Pt 3):873-878

Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression.

Liao W; Rudling M; Angelin B
Article: JOURNAL OF CLINICAL INVESTIGATION. 1996;97(2):292-299

Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.

Rudling M; Olivecrona H; Eggertsen G; Angelin B
Article: ENDOCRINOLOGY. 1995;136(9):3767-3773

Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells.

Parini P; Angelin B; Lobie PE; Norstedt G; Rudling M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1995;15(7):847-849

Hormonal regulation of serum lipoprotein(a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I.

Olivecrona H; Johansson AG; Lindh E; Ljunghall S; Berglund L; Angelin B
Article: JOURNAL OF CLINICAL INVESTIGATION. 1995;95(5):2161-2169

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.

Reynisdottir S; Eriksson M; Angelin B; Arner P
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1995;25(4):271-280

Studies on lipoprotein metabolism in a family with jejunal chylomicron retention.

Nemeth A; Myrdal U; Veress B; Rudling M; Berglund L; Angelin B
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1995;80(4):1113-1117

Growth hormone treatment does not alter biliary lipid metabolism in healthy adult men.

Olivecrona H; Ericsson S; Angelin B
Article: HEPATOLOGY. 1995;21(4):1025-1030

Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase.

Ståhlberg D; Reihnér E; Rudling M; Berglund L; Einarsson K; Angelin B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1995;15(1):121-127

Gemfibrozil enhances platelet activity in patients with combined hyperlipoproteinemia.

Bröijersén A; Eriksson M; Angelin B; Hjemdahl P
Visa fler

Alla övriga publikationer

Review: JOURNAL OF INTERNAL MEDICINE. 2023;294(5):582-604

Neurobiology of eating behavior, nutrition, and health.

Stover PJ; Field MS; Andermann ML; Bailey RL; Batterham RL; Cauffman E; Frühbeck G; Iversen PO; Starke-Reed P; Sternson SM; Vinoy S; Witte AV; Zuker CS; Angelin B
Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(4):587-603

Nutrition and stem cell integrity in aging.

Stover PJ; Field MS; Brawley HN; Angelin B; Iversen PO; Frühbeck G
Other: JOURNAL OF INTERNAL MEDICINE. 2022;292(4):690

In memoriam: Rolf Hultcrantz (1949-2022) Obituary

Angelin B; Andersson J; Ekbom A; Melander O; Dahlqvist P; Smedby KE; Lerm M; Hedbom T; Cooper E; Forsberg N; de Faire U
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2019;286(6):723-725

How to handle hypertriglyceridaemia in acute pancreatitis - Still a vote for conservatives?

Eriksson M; Angelin B
Corrigendum: JOURNAL OF LIPID RESEARCH. 2018;59(11):2253

Erratum: Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.

Ghosh M; Galman C; Rudling M; Angelin B
Letter: JOURNAL OF INTERNAL MEDICINE. 2018;283(6):604-606

Unique case of cerebrotendinous xanthomatosis revisited: All the mutations responsible for this disease are present in the CYP27A1 gene.

Jiao H; Olin M; Hansson M; Eggertsen G; Eriksson M; Angelin B; Björkhem I
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2018;32:63

TESTOSTERONE REDUCES CIRCULATING PCSK9 BUT DOES NOT INFLUENCE CHOLESTEROL OR BILE ACID SYNTHESIS IN HEALTHY MALES

Laskar MG; Beckman L; Laskar A; Garevik N; Ekstrom L; Rudling M; Angelin B
Meeting abstract: ATHEROSCLEROSIS. 2017;263:E62

THE USE OF GENOTYPING AS A FIRST STEP IN MOLECULAR DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA

Benedek P; Angelin B; Duvefelt K; Hong J; Kere J; Rudling M; Eriksson M
Review: JOURNAL OF INTERNAL MEDICINE. 2017;281(6):534-553

Can LDL cholesterol be too low? Possible risks of extremely low levels.

Olsson AG; Angelin B; Assmann G; Binder CJ; Björkhem I; Cedazo-Minguez A; Cohen J; von Eckardstein A; Farinaro E; Müller-Wieland D; Parhofer KG; Parini P; Rosenson RS; Starup-Linde J; Tikkanen MJ; Yvan-Charvet L
Editorial comment: TRENDS IN MOLECULAR MEDICINE. 2017;23(2):97-99

Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds?

Bonde Y; Angelin B
Meeting abstract: ATHEROSCLEROSIS. 2016;252:E197

LIPIDS AND LIPOPROTEINS. POSTTRANSCRIPTIONAL REGULATION OF THE LDLR BY ACTH TREATMENT - IMPORTANCE OF PCSK9 IN LIVER WHILE IDOL TAKES THE SCENE IN THE ADRENALS

Laskar MG; Angelin B; Rudling M
Letter: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2015;100(12):L130-L131

Letter to the Editor: Potential Role for FGF21 as a Mediator of Thyroid Hormone Effects on Metabolic Regulation.

Bonde Y; Angelin B; Rudling M
Review: CURRENT OPINION IN LIPIDOLOGY. 2013;24(4):327-331

Interstitial fluid lipoproteins.

Lundberg J; Rudling M; Angelin B
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2013;273(1):3-5

Fifty years of lipoprotein(a) -- the magical mystery tour continues.

Angelin B
Review: CELL METABOLISM. 2012;16(6):693-705

Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.

Angelin B; Larsson TE; Rudling M
Review: NUTRITION REVIEWS. 2012;70 Suppl 1:S57-S86

Discussion from the 24(th) Marabou Symposium: Nutrition and the human microbiome.
Meeting abstract: JOURNAL OF HEPATOLOGY. 2012;56:S556

GUT MICROBIOTA REGULATES BILE ACID METABOLISM BY REDUCING THE LEVELS OF TAURO-BETAMURICHOLIC ACID, A NATURALLY OCCURRING FXR ANTAGONIST

Islam S; Felin J; Jantti S; Hyotylainen T; Wahlstrom A; Marschall H-U; Bamberg K; Angelin B; Oresic M; Backhed F
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):34

DIETARY SUGAR INCREASES LIVER CHOLESTEROL PARTLY THROUGH REDUCED BILIARY SECRETION OF CHOLESTEROL AND BY REDUCED SYNTHESIS OF BILE ACIDS

Lundberg J; Persson L; Galman C; Angelin B; Rudling M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):13

REGULATION OF BILE ACID AND CHOLESTEROL METABOLISM BY ENDOGENOUS THYROID HORMONE IN HUMANS

Bonde Y; Angelin B; Rudling M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):7

LIPID-LOWERING EFFECTS OF THE THYROID HORMONE ANALOGUE EPROTIROME REQUIRES FUNCTIONAL LDL RECEPTORS: STUDIES IN A HOMOZYGOUS FH PATIENT

Benedek P; Angelin B; Kristensen J; Rudling M; Eriksson M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):23

ACUTE STIMULATION OF ENDOGENOUS ESTROGEN IN WOMEN ALTERS CHOLESTEROL METABOLISM AND REDUCES PCSK9 AND LDL CHOLESTEROL LEVELS

Persson L; Henriksson P; Westerlund E; Hovatta O; Angelin B; Rudling M
Review: CURRENT OPINION IN LIPIDOLOGY. 2010;21(6):499-506

Lipid lowering with thyroid hormone and thyromimetics.

Angelin B; Rudling M
Editorial comment: OBSTETRICAL & GYNECOLOGICAL SURVEY. 2010;65(8):512-513

Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia

Ladenson PW; Kristensen JD; Ridgway EC; Olsson AG; Carlsson B; Klein I; Baxter JD; Angelin B
Letter: JOURNAL OF INTERNAL MEDICINE. 2009;265(2):296-298

Is endometroid cancer of the ovaries a late manifestation of Alström syndrome?

Moberg E; Hjerpe E; Ehrsson RJ; Möller C; Angelin B
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2008;9(1):33

CHOLESTEROL REGULATES ACAT2 GENE EXPRESSION AND ENZYME ACTIVITY IN HUMAN HEPATOMA CELLS

Pramfalk C; Angelin B; Eriksson M; Parini P
Corrigendum: JOURNAL OF INTERNAL MEDICINE. 2008;263(4):459

Circulating intestinal broblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man (vol 260, pg 530, 2006)

Lundasen T; Gaelman C; Angelin B; Rudling M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):43

HNF4 alpha is essential for ACAT2 regulation in human: Lesson from the mody patients

Pramfalk C; Karlsson E; Eriksson M; Angelin B; Groop L; Rudel LL; Parini P
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):21

Cholestyramine up-regulates the expression of PCSK9 in human livers

Nilsson L-M; Abrahamsson A; Angelin B; Gustafsson U; Sahlin S; Parini P; Einarsson C
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):21

Reduction of ACAT2 is an important effect of cholesterol synthesis inhibition in human livers

Parini P; Gustafsson U; Einarsson C; Shalin S; Rudling M; Angelin B; Rudel LL; Eriksson M
Corrigendum: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006;348(1):326

Obesity and disturbed lipoprotein profile in estrogen receptor-α-deficient male mice (vol 278, pg 640, 2000)

Ohlsson C; Hellberg N; Parini P; Vidal O; Bohlooly-Y M; Rudling M; Lindberg MK; Warner M; Angelin B; Gustafsson J-A
Review: LAKARTIDNINGEN. 2006;103(10):751-752

[The apoB/apoA-I ratio is better myocardial infarction marker than lipids].

Walldius G; Angelin B; Eriksson M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):188-189

Intestinal cholesterol absorption is not a major determinant for the age-induced increase in plasma cholesterol in rats

Galman C; Matasconi M; Parini P; Angelin B; Rudling M
Editorial comment: CELL METABOLISM. 2005;2(4):209-210

Telling the liver (not) to make bile acids: a new voice from the gut?

Angelin B
Letter: JOURNAL OF INTERNAL MEDICINE. 2005;257(3):313-314

Risk for fatal statin-induced rhabdomyolysis as a consequence of misinterpretation of 'evidence-based medicine'.

Eriksson M; Angelin B; Sjöberg S
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2003;4(2):233

New molecular effects of cholesterol synthesis inhibition on hepatic cholesterol metabolism in humans

Eriksson M; Davis MA; Gustafsson U; Willingham MC; Einarsson C; Angelin B; Sahlin S; Rudel LL; Parini P
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2003;4(2):233

The hypophysectomized mouse - a feasible model for the further dissection of the role of the pituitary on lipid metabolism

Matasconi M; Angelin B; Rudling M
Review: LAKARTIDNINGEN. 2001;98(36):3788-3793

[Blood lipid derangement common in peripheral artery disease. Lipid-lowering agents may alleviate symptoms and slow the atherosclerotic process].

Bröijersén A; Wiklund B; Angelin B
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2001;249:1-2

Journal of Internal Medicine and the new century

Holm G; Angelin B; de Faire U; Fagrell B; Ljunghall S
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2001;250(1):1-2

Renewal of the Journal

Holm G; Angelin B; Fagrell B; De Faire U; Ljunghall S
Letter: LANCET. 2000;355(9198):148

Insulin-like growth factor I for growth hormone therapy.

Liao W; Rudling M; Angelin B
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2000;247(1):1-2

Journal of internal medicine and the new century.

Holm G; Angelin B; De Faire U; Fagrell B; Ljunghall S
Review: CURRENT OPINION IN LIPIDOLOGY. 1999;10(3):269-274

Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era?

Angelin B; Eriksson M; Rudling M
Meeting abstract: ATHEROSCLEROSIS. 1999;144:112-113

VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression:: Involvement of the VLDL receptor

Nilsson L; Gåfvels M; Musakka L; Ensler K; Strickland DK; Angelin B; Hamsten A; Eriksson P
Meeting abstract: ATHEROSCLEROSIS. 1999;144:93

Growth hormone infusion to LDL-receptor knock-out mice reduces plasma cholesterol and stimulates bile acid synthesis

Rudling M; Angelin B
Published conference paper: GROWTH HORMONE & IGF RESEARCH. 1999;9 Suppl A:1-7

Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans.

Rudling M; Parini P; Angelin B
Letter: TRANSPLANTATION. 1998;65(5):759

Dose-dependent reduction of bile secretion in cyclosporine-treated rats (reply)

Ericzon BG; Eusufzai S; Söderdahl G; Duraj F; Einarsson K; Angelin B
Review: CURRENT OPINION IN LIPIDOLOGY. 1997;8(6):337-341

Therapy for lowering lipoprotein (a) levels.

Angelin B
Meeting abstract: ATHEROSCLEROSIS. 1997;134(1-2):188

Platelet function in hypercholesterolemia - importance of combined hyperlipidemia

Broijersen A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Letter: JOURNAL OF HEPATOLOGY. 1997;26(5):1157

Bile acid kinetics and biliary lipid composition in cystic fibrosis - Reply

Strandvik B; Einarsson K; Lindblad A; Angelin B
Letter: NEPHRON. 1996;72(3):483

Decreased cyclosporine levels during gemfibrozil treatment of hyperlipidemia after kidney transplantation.

Fehrman-Ekholm I; Jogestrand T; Angelin B
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 1996;239(1):1-2

Journal of Internal medicine - A journal for the internist

Holm G; Angelin B; DeFaire U; Fagrell B; Ljunghall S
Review: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1995;25(4):215-224

1994 Mack-Forster Award Lecture. Review. Studies on the regulation of hepatic cholesterol metabolism in humans.

Angelin B
Addendum: ENDOCRINOLOGY. 1995;136(2):795

Cloning of a complementary deoxyribonucleic acid encoding the murine homolog of the very low density lipoprotein/apolipoprotein-E receptor: expression pattern and assignment of the gene to mouse chromosome 19".

Gafvels ME; Paavola LG; Boyd CO; Nolan PM; Wittmaack F; Chawla A; Lazar MA; Bucan M; Angelin B; Strauss JF
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(1):1125

FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.

Söderdahl G; Groth CG; Angelin B; Duraj F; Einarsson K; Ericzon BG
Visa fler

Om mig

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI